SCHEDULE: Janus Henderson Discloses 9.99% Stake in Equillium

Janus Henderson Group plc has reported a 9.99% beneficial ownership stake in Equillium, Inc., including common stock and exercisable warrants.

Summary

• Janus Henderson Group plc, a Jersey-based investment adviser and parent holding company, has filed a Schedule 13G indicating beneficial ownership in Equillium, Inc.
• The filing reports an aggregate beneficial ownership of 6,083,239 shares of Equillium, Inc. common stock.
• This ownership represents 9.99% of the class of securities.
• Janus Henderson Group plc holds shared voting power and shared dispositive power over all 6,083,239 shares.
• The reported shares include certain pre-funded and/or common warrants, which are only exercisable within 60 days to the extent that beneficial ownership does not exceed 9.99%.
• An additional 12,858,179 pre-funded and 5,036,469 common warrants are not reflected in the reported figures due to the 9.99% ownership limitation.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Equillium, Inc.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to a significant institutional investor taking a stake, which can be seen as a vote of confidence. However, the disclosure of a large number of unexercised warrants that could lead to future dilution introduces a potential negative aspect.

Positives

• A significant institutional investor, Janus Henderson Group plc, has taken a substantial stake in Equillium, Inc., potentially signaling confidence in the company's long-term prospects.
• The ownership is held in the ordinary course of business, indicating a passive investment rather than an activist stance that could create uncertainty.

Negatives

• The existence of a large number of unexercised warrants (over 17 million) that are not reflected in the current ownership due to a 9.99% beneficial ownership cap could lead to significant dilution if these warrants become fully exercisable and are converted in the future.

Risks

• Potential future dilution from the exercise of a substantial number of pre-funded and common warrants (12,858,179 pre-funded and 5,036,469 common warrants) that are currently not reflected in the beneficial ownership due to a 9.99% ownership limitation.

Future Outlook

This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance from Equillium, Inc. or Janus Henderson Group plc regarding Equillium's future performance.

Management Comments

• Kristin Mariani, Head of North America Compliance, CCO for Janus Henderson Group plc, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of Equillium, Inc.

Industry Context

Schedule 13G filings are standard disclosures by institutional investors who acquire more than 5% of a company's voting stock, indicating a passive investment intent. Janus Henderson Group plc is a global asset manager, and its investment in Equillium, Inc. reflects its portfolio management activities.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor may be viewed positively, potentially increasing investor confidence. However, the large number of unexercised warrants held by Janus Henderson could lead to future dilution, impacting existing shareholders' equity percentage.
• Management: Awareness of a large, passive institutional holder may influence strategic decisions, though Janus Henderson has certified no intent to influence control.

Key Dates

Recommendation

The filing indicates a significant institutional investment by Janus Henderson Group plc in Equillium, Inc., which could be seen as a positive signal. However, the presence of a substantial number of unexercised warrants, which are not currently reflected in the 9.99% ownership due to a beneficial ownership cap, introduces a potential for future dilution. This creates a mixed signal, suggesting a 'hold' recommendation as the positive of institutional interest is balanced by the potential for future dilution, warranting further monitoring of Equillium's operational performance and capital structure.

Keywords

Equillium, Janus Henderson, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Investment, EQ, Investment Adviser, Holding Company